PECULIARITIES OF IMMUNOLOGICAL INDICATORS IN ACUTE MYELOBLASTIC LEUKEMIA IN DYNAMICS

EHA Library, Olga Smirnova, 216226

DYNAMICS OF METABOLIC INDICATORS OF ACUTE NON-LYMPHOBLASTIC LEUKEMIA

EHA Library, Olga Smirnova, 216227

ANTI-CD CELL-BINDING ANTIBODY MICROARRAY FOR INTEGRATION OF MORPHOLOGY AND IMMUNOPHENOTYPING IN ACUTE LEUKEMIA DIAGNOSIS

EHA Library, Sofya Kuznetsova, 216228

SRSF2 GENE MUTATIONS ARE ASSOCIATED WITH TP53Γ EXPRESSION LEVELS AND OVERALL SURVIVAL IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML).

EHA Library, Karolina Matiakowska, 216229

INVESTIGATING THE EFFECT OF C-MYC PROTO-ONCOGENE INHIBITION IN ACUTE PROMYELOCYTIC LEUKEMIA

EHA Library, Mohammad sayyadi, 216230

THE ROLE OF S100A4 IN ACUTE MYELOID LEUKEMIA

EHA Library, Bader Alanazi, 216231

EXPLORATORY BIOMARKER ANALYSIS IN AML PATIENTS TREATED WITH ORAL SYK INHIBITOR ENTOSPLETINIB (GS-9973)

EHA Library, Veerendra Munugalavadla, 216232

INHIBITION OF DNA METHYLTRANSFERASES BY VOLASERTIB IN HMA RESISTANT CELL LINES

EHA Library, Sun-Hye Ko, 216233

TO IDENTIFY PROGNOSTIC BIOMARKER AND GENE REGULATION BY TCGA DATASET: ALDH1A1 IN ACUTE MYELOID LEUKEMIA

EHA Library, Hai Yi, 216234

THE PROLIFERATION INDEX OF BONE MARROW CELLS FOR DIFFERENTIAL DIAGNOSIS OF CHRONIC MYELOMONOCYTIC LEUKEMIA VS. ACUTE MONOBLASTIC/MONOCYTIC LEUKEMIAS

EHA Library, Pilar Leoz Allegretti, 216235

MDR1 GENE DETECTED IN VITRO HAVE A PROGNOSTIC SIGNIFICANCE IN LEUKEMIA PATIENTS

EHA Library, Maria Kolesnikova, 216236

KARYOTYPE COMPLEXITY AND CHARACTERIZATION OF CHILDHOOD ACUTE MYELOID LEUKEMIA (AML) IN PAKISTAN

EHA Library, Zeeshan Ahmed, 216237

SYNERGISTIC EFFECTS OF PI3K AND C-MYC CO-TARGETING IN ACUTE MYELOID LEUKEMIA: PROPOSING NOVEL THERAPEUTIC POTENTIAL FOR AML

EHA Library, niknam riyahi, 216238

JAGGED-1 EXPRESSION IN MESENCHYMAL STROMAL CELLS HAS DISTINCT EFFECTS ON FLT3 MUTATED LEUKEMIA CELLS

EHA Library, Manja Wobus, 216239

PHARMACOLOGICAL INHIBITION OF WIP1 SENSITIZES ACUTE MYELOID LEUKEMIA CELLS TO MDM2 INHIBITORS

EHA Library, Maria Chiara Fontana, 216240

STRATEGIES OF AFFECTING CELLULAR LOCALIZATION TO OVERCOME RESISTANCE IN FLT3-ITD-POSITIVE AML CELLS

EHA Library, Ulf Schnetzke, 216241

MOLECULAR CHARACTERIZATION OF PEDIATRIC ACUTE MYELOID LEUKEMIA: RESULTS OF A PROSPECTIVE MULTICENTRIC STUDY IN RUSSIA

EHA Library, Agnesa Panfyorova, 216242

RISK FACTORS AND OUTCOMES OF PATIENTS WITH RELAPSED CORE-BINDING FACTOR-POSITIVE ACUTE MYELOID LEUKEMIA

EHA Library, Marijana Virijevic, 216243

OUTCOME OF ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA IN A SINGLE INSTITUTION

EHA Library, Ana García-Noblejas, 216244

REGISTRY FOR THE OFF-LABEL USE OF VENETOCLAX IN PATIENTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA

EHA Library, Rabia Shahswar, 216245

FEASIBILITY AND EFFICACY OF INTENSIVE SALVAGE TREATMENTS FOR ELDERLY PATIENTS WITH RELAPSED ACUTE MYELOID LEUKEMIA

EHA Library, Bernardi Massimo, 216246

IMPACT OF BONE MARROW ASPIRATE TREGS ON THE RESPONSE RATE OF YOUNGER NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA PATIENTS

EHA Library, Mario Delia, 216247

IMPORTANCE OF CLINICAL RISK IN CYTOGENETIC-MOLECULAR FAVOURABLE RISK AML WITH NPM MUTATED, FLT3-ITD UNMUTATED AND NORMAL KARYOTYPE.

EHA Library, Maria Vittoria Dubbini, 216248

RARE REPORT OF PROMYELOCYTIC SARCOMA AFTER RENAL TRANSPLANT

EHA Library, Li-Jing Shen, 216249

INTENSIVE INDUCTION TREATMENT OF ACUTE MYELOID LEUKEMIA IN PATIENTS AGED ABOVE 60 IN SHATHD BETWEEN 1.01.2010 AND 1.01.2018, PROGNOSTIC FACTORS FOR INDUCTION MORTALITY

EHA Library, Stefan Lozenov, 216250

OUTPATIENT-BASED HIGH DOSE CYTARABINE FOR PATIENTS WITH ACUTE MYELOID LEUKEMIA: SAFE, FEASIBLE AND COST EFFECTIVE APPROACH

EHA Library, Panayotis Kaloyannidis, 216251

REAL LIFE SINGLE CENTER EXPERIENCE WITH TREATMENT REGIMENS IN ADULT PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA – EARLY DEATH RATES (2002-2018)

EHA Library, Iveta Oravcova, 216252

EARLY MORTALITY IN ACUTE MYELOID LEUKEMIA WITH HYPERLEUKOCYTOSIS

EHA Library, Andreea Moicean, 216253

PHARMACOKINETICS OF HU5F9-G4 A FIRST IN CLASS ANTI-CD47 ANTIBODY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Balaji Agoram, 216254

DOES THE ICU ADMISSION OF THE DE NOVO AML PATIENTS DURING REMISSION INDUCTION HAVE INFLUENCE ON THE LONG-TERM OUTCOME?

EHA Library, Aleksei Bazhenov, 216255

AZACITIDINE OR DECITABINE FRONTLINE THERAPY FOR ACUTE MYELOID LEUKEMIA IN ELDERLY PATIENTS?

EHA Library, Silvia Imbergamo, 216256

AN EFFECTIVE TOOL FOR COMPREHENSIVE GERIATRIC ASSESSMENT IN ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Chun-Li Zhang, 216257

IMPACT OF DIFFERENT BY INTENSITY CONSOLIDATION REGIMENS ON MINIMAL RESIDUAL DISEASE REDUCTION AND RELAPSE INCIDENCE IN ADULTS WITH ACUTE MYELOID LEUKEMIA.

EHA Library, Tatiana Lobanova, 216258

CORRELATION OF INTERLEUKIN-6, INTERLEUKIN-10, AND TRANSFORMING GROWTH FACTOR BETA SERUM LEVELS WITH THE RESPONSE TO INDUCTION CHEMOTHERAPY IN NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA PATIENTS

EHA Library, Tareq Salah, 216259

REFRACTORY/RELAPSED ACUTE MYELOID LEUKEMIA PATIENTS WITH HIGH CD117 EXPRESSION BUT WITHOUT FLT3-ITD MUTATION COULD BE A SPECIAL GROUP WITH GOOD RESPONSES TO SORAFENIB TREATMENT ALONE

EHA Library, Jianhui Xu, 216260

DETECTION OF PML-RARA IN APL: COMPARING FISH, PCR AND CONVENTIONAL KARYOTYPING

EHA Library, Marta Pereira, 216261

BRAF MUTATION IN BOTH HAIRY CELL LEUKEMIA AND PAPILLARY THYROID CANCER IN THE SAME PATIENT.

EHA Library, Shehab Fareed Abdelgabber, 216262

DEFINING A TECHNICAL WORKFLOW FOR GENE EXPRESSION PROFILING IN MRD+ CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Alba Mora, 216263

DRUG SENSITIVITY SCREENING IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) FOR PRECISION CANCER THERAPY.

EHA Library, Deepak balaji Thimiri Govinda Raj, 216264

EXPRESSION OF THE APOPTOSIS-RELEATED GENES IN PATIENTS WITH NEWLY DIAGNOSED CHRONIC LYMPHOCYTIC LEUKEMIA IN CLINICAL DATA CONTEXT

EHA Library, Sergey Zakharov, 216265

TARGETING THE INTERPLAY BETWEEN HSP70 (HEAT SHOCK PROTEIN OF 70KDA) AND HSF1 (HEAT SHOCK FACTOR 1) IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Flavia Raggi, 216266

A METHYL-CPG BINDING DOMAIN SEQUENCING STUDY SHOWED DYSREGULATED METHYLATION IN GENES INVOLVED IN CANCER, IMMUNITY, LYMPHOID DIFFERENTIATION AND MAJOR SIGNALING PATHWAYS IN ASIAN CLL

EHA Library, Eunyup Lee, 216267

THE IMPORTANCE OF MOLECULAR AND CYTOGENETIC ABERRATIONS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Elena Nazarova, 216268

MUTATIONAL STATUS, IGHV GENE REARRANGEMENTS AND STEREOTYPED RECEPTORS IN CHRONIC LYMPHOCYTIC LEUKEMIA: RESULTS FROM A SOUTH AMERICAN MULTICENTER STUDY

EHA Library, Carmen Stanganelli, 216269

THE POSSIBLE ROLE OF TLR2 AND TLR9 RECEPTOR DYSFUNCTION IN THE PATHOGENESIS AND PROGRESSION OF CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Agnieszka Szymczyk, 216270

CHARACTERIZATION OF IGHVDJ REARRANGEMENTS AND CHROMOSOMAL ALTERATIONS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Miguel Ángel Perera Álvarez, 216271

QUADRANT ANALYSIS OF DRUG APPROVAL AND EMERGING TREATMENT TRENDS IN CHRONIC LYMPHOCYTIC LEUKEMIA – A RETROSPECTIVE STUDY ON PIVOTAL CLINICAL TRIALS

EHA Library, Maneesha Chhikara, 216272

MONOCLONAL GAMMOPATHY AND HYPOGAMMAGLOBULINEMIA AS INDEPENDENT PROGNOSTIC FACTORS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: A RETROSPECTIVE MONOCENTRIC EXPERIENCE.

EHA Library, Luca Laurenti, 216273

MONOCLONAL B-CELL LYMPHOCYTOSIS IN GREEK POPULATION

EHA Library, Eleftheria Ztriva, 216274

THE EXPRESSION LEVEL OF CD 177 IS INCREASED IN PATIENTS WITH CHRONIC LYMPHOPROLIFERATIVE DISEASES AND MYELOID NEOPLASIAS

EHA Library, Irina Krobinets, 216275

UNCLASSIFIABLE ISOLATED MONOCLONAL HYPERLYMPHOCYTOSIS: COMPREHENSIVE DESCRIPTION OF A RETROSPECTIVE COHORT

EHA Library, Michaël Degaud, 216276

IMMUNOLOGICAL RECONSTITUTION AND PLATELET DISFUNCTION DURING IBRUTINIB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Idanna Innocenti, 216277

ATRIAL FIBRILLATION IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA RECEIVING TREATMENT WITH IBRUTHINIB.

EHA Library, Gennady Gendlin, 216278

SAFETY AND EFFICACY OF BENDAMUSTINE AND RITUXIMAB COMBINATION CHEMOTHERAPY AS FIRST LINE TREATMENT IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: A SINGLE CENTRE EXPERIENCE FROM NORTH INDIA

EHA Library, Anil Tripathi, 216279

ANALYSIS OF PERCENT IDENTITY OF IGHV MUTATION AS PROGNOSTIC FACTOR IN CLL PATIENTS TREATED WITH FLUDARABINE, CYCLOFOSFAMIDE AND RITUXIMAB: A SINGLE CENTRE EXPERIENCE

EHA Library, Annamaria giordano, 216280

ADVANCED DATA-MINING METHODS REVEALED FOUR SUBGROUPS AMONG HIGH-RISK CLL PATIENTS

EHA Library, Peter Turcsanyi, 216281

HIGH DOSE METHYLPREDNISOLONE AND RITUXIMAB IN RELAPSED PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Regina Pileckyte, 216282

MULTICENTRIC REAL LIFE COHORT OF UNSELECTED CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS (CLL): MOLECULAR ANALYSIS, CLINICAL INTEGRATION AND PROGNOSTIC IMPLICATIONS.

EHA Library, Roberta MURRU, 216283

IBRUTINIB IN THE TREATMENT OF EARLY RELAPSE OF CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Natalia Timofeeva, 216284

DOES THE DOSE MODIFICATION OF FLUDARABINE, CYCLOPHOSPHAMIDE, RITUXIMAB (FCR) IMPACT TREATMENT OUTCOME IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA? ANSWER BASED ON SINGLE CENTER „REAL-LIFE“ DATA

EHA Library, Vojin Vukovic, 216285

ASSOCIATION OF INITIAL PROGNOSTIC PARAMETERS AND REQUIREMENT FOR TREATMENT IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Aysun SENTURK YIKILMAZ, 216286

DISCORDANCE IN THE THRESHOLDS OF EARLY RELAPSE IN CLL GUIDELINES

EHA Library, Vladimir Strugov, 216287

INFLUENCE OF INTENSITY CHEMOTHERAPY ON THE FREQUENCY OF MRD NEGATIVE REMISSIONS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Maria Mikhaleva, 216288

SAFETY PROFILE OF IBRUTINIB: A RETROSPECTIVE ANALYSIS OF 31 PATIENTS

EHA Library, Jasone Uriarte Elguezabal, 216289

COMPARISON OF CLINICAL FEATURES AND SURVIVAL BETWEEN YOUNG AND OLD CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: A SINGLE CENTRE STUDY FROM TURKEY

EHA Library, Rafet Eren, 216290

DESIGN, SYNTHESIS, ANTI-PROLIFERATIVE, CELL CYCLE INHIBITORY AND IN-VIVO ANTILEUKEMIC ACTIVITY OF NOVEL THIAZOLIDINEDIONES IN COMBINATION WITH IMATINIB.

EHA Library, Hardik Joshi, 216291

EFFECTS OF DIFFERENT TKIS ON CHRONIC MYELOID LEUKEMIA STEM CELLS AND TKIS DISCONTINUATION

EHA Library, Lin Jiang, 216292

ASSOCIATION OF PLK1 AND AURORA KINASE INHIBITORS WITH WEE1 INHIBITORS: A NOVEL THERAPEUTIC APPROACH FOR BLAST CRISIS CML

EHA Library, Manuela Mancini, 216293

WNT PATHWAY IS INVOLVED IN BCR-ABL1-INDEPENDENT RESISTANCE TO TKIS IN CHRONIC MYELOID LEUKEMIA PATIENTS

EHA Library, Susanna Grassi, 216294

AVOIDING BCR/ABL EXPRESSION IN CHRONIC MYELOID LEUKEMIA CELLS BY CRISPR/CAS9 SYSTEM GENOME EDITION TOOL.

EHA Library, Verónica Alonso-Pérez, 216295

OUTCOME OF FRONTLINE TREATMENT WITH GENERIC OF IMATINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA

EHA Library, Samia menif, 216296

MTORC2 COMPLEX SUSTAINS LEUKEMIC STEM CELL SELF-RENEWAL BY NUCLEAR RELOCALIZATION OF ITS COMPONENTS

EHA Library, Cristina Panuzzo, 216297

THE ROLE OF LEUKEMIC STEM CELLS AND EARLY PROGENITOR CELLS IN CHRONIC MYELOGENOUS LEUKEMIA RECURRENCE AFTER THE DISCONTINUATION OF TREATMENT WITH TKI

EHA Library, Tetiana Perekhrestenko, 216298

SALIVARY PROTEOMIC PROFILE OF PATIENTS WITH CHRONIC MYELOID LEUKEMIA DISTINGUISHES TKIS RESPONDERS FROM NON-RESPONDERS

EHA Library, Francesca Perutelli, 216299

MYOFIBROBLASTS DERIVED FROM CHRONIC MYELOGENOUS LEUKEMIA PATIENTS EXPRESSED BCR-ABL TRANSCRIPT WHEN CULTURED WITH INTERLEUKIN-1 BETA

EHA Library, Naoki Shirafuji, 216300

BEX1 GENE EXPRESSION IS A PREDICTOR FOR THE RESPONSE TO NILOTINIB IN CHRONIC MYELOGENOUS LEUKEMIA

EHA Library, Dong-Yeop Shin, 216301

NILOTINIB VS IMATINIB IN ALBANIAN PATIENTS WITH NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE.

EHA Library, Alma Cili, 216302

ALTERED EXPRESSION OF JAK-STAT PATHWAY AS POSSIBLE PREDICTIVE MARKER IN PATIENTS AFFECTED BY CHRONIC MYELOID LEUKEMIA RECEIVING TYROSIN KINASE INHIBITORS (TKIS)

EHA Library, Susanna Grassi, 216303

BCR-ABL EXON 7 DELETION CAUSES TKI RESISTANCE IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA


EHA Library, Ilya Mikhailov, 216304

LW-213 TRIGGERED G2/M CELL CYCLE ARREST AND APOPTOSIS OF CHRONIC MYELOGENOUS LEUKEMIA CELLS THROUGH SUPPRESSION OF CDK9-RELATED SIGNALING PATHWAYS

EHA Library, Jingyan XU, 216305

DOWN-REGULATION OF MUSASHI2 AFFECTS ON MTOR SIGNALING AND INDUCES APOPTOSIS IN CD34+ CHRONIC MYELOID LEUKEMIA CELLS

EHA Library, Majid Mossahebi-mohammadi, 216306

HLA CLASS I AND CLASS II ALLELE FREQUENCIES IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA AND THEIR EFFECT ON SURVIVAL

EHA Library, Isik Kaygusuz Atagunduz, 216307

LONG-TERM OUTCOMES OF EARLY CP CML PATIENTS WHO HAVE ACHIEVED CCYR BUT NOT MMR AFTER 24 MONTHS ON FRONTLINE IMATINIB THERAPY

EHA Library, Sung-Hyun Kim, 216308

INTERDISCIPLINARY APPROACH FOR THE MANAGEMENT OF CARDIOVASCULAR RISK FACTORS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA

EHA Library, Jon Badiola, 216309

EVALUATION OF LOW LEVEL DETECTION OF MAJOR BCR-ABL1 MRNA IN CHRONIC MYELOID LEUKEMIA (DOMEST ADDITIONAL STUDY)

EHA Library, Hiroaki Kitamura, 216310

TREATMENT- FREE REMISSION UP TO 12 YEARS. INTERIM ANALYSIS OF A REGIONAL GERMAN CML - REGISTER. (A CONTRIBUTION OF GERMAN CML - ALLIANCE)

EHA Library, Dietrich KÄMPFE, 216311

GASTRIC CONDITIONS AS PROXY FOR HELICOBACTER PYLORI INFECTION AND RISK OF CHRONIC MYELOID LEUKEMIA

EHA Library, Gunnar Larfors, 216312

AN APPROACH TO DRUG-TO-DRUG INTERACTIONS IN CML PATIENTS TREATED WITH TYROSINE KINASE INHIBITORS. AN OBSERVATIONAL STUDY OF THE SPANISH CML GROUP (GELMC).

EHA Library, Ignacio Gómez-Centurión, 216313

IMATINIB TREATMENT IN ELDERLY PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML) IN THE REAL-LIFE SETTING: UPDATED DATA OF THE CERRAHPASA CML COHORT

EHA Library, Deniz Ozmen, 216314

COMPARISON OF MOLECULAR RESPONSES AND OUTCOMES IN CHRONIC MYELOID LEUKEMIA – CHRONIC PHASE PATIENTS TREATED WITH NILOTINIB INITIALLY FOLLOWED BY IMATINIB, COMPARED TO TREATMENT WITH IMATINIB UPFRONT

EHA Library, Aditi Jain, 216315

EVALUATION OF THE CEPHEID XPERT® BCR-ABL ULTRA ASSAY¥ IN CLINICAL SPECIMENS IN COMPARISON TO THE QIAGEN® IPSOGEN BCR-ABL1 MBCR IS-MMR ASSAY

EHA Library, Gwo-Jen Day, 216316

EFFICACY AND SAFETY OF SWITCHING FROM BRANDED TO GENERIC IMATINIB IN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA: A STUDY OF THE GRUPPO TRIVENETO LMC ON 294 PATIENTS

EHA Library, Massimiliano BONIFACIO, 216317

FREQUENCY OF GATEKEEPER MUTATION IN THE NON-RESPONDING CHRONIC MYELOID LEUKEMIA PATIENTS

EHA Library, Bushra Kaleem, 216318

THE RESTORING OF DEEP MOLECULAR RESPONSE IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA AND MOLECULAR RELAPSE AFTER TREATMENT DISCONTINUATION

EHA Library, Ekaterina Chelysheva, 216319

REAL-WORLD EVIDENCE OF MOLECULAR RESPONSE TO TYROSINE KINASE INHIBITORS FROM CHINA SUPPORTS EUROPEAN LEUKEMIANET 2013 RECOMMENDATIONS FOR THE MANAGEMENT OF CHRONIC MYELOID LEUKAEMIA.

EHA Library, Hua YIN, 216320

MATHEMATICAL MODELLING REVEALS THE POTENTIAL FOR CONSIDERABLE DOSE REDUCTIONS IN TYROSINE KINASE INHIBITOR TREATED CHRONIC MYELOID LEUKEMIA

EHA Library, Ingo Roeder, 216321

IMPROVING EUTOS SCORE SENSITIVITY BY USING SERUM ALPHA/BETA TRYPTASE-1 LEVEL IN NEWLY DIAGNOSED EGYPTIAN PATIENTS WITH CHRONIC PHASE CHRONIC MYELOID LEUKEMIA IN CORRELATION TO THE MOLECULAR MILSTONES

EHA Library, Ayman Youssef, 216322

ADDITIONAL CYTOGENETIC ABNORMALITIES IN CHRONIC MYELOID LEUKEMIA; EXPERIENCE FROM PAKISTAN

EHA Library, Nida Anwar, 216323

ANALYSIS OF SERUM LIPIDS, CARDIOVASCULAR RISK AND INDICATION FOR STATIN THERAPY AT THE START AND DURING IMATINIB AND NILOTINIB THERAPY IN DE NOVO CML PATIENTS– RESULTS FROM REAL-LIFE PROSPECTIVE STUDY

EHA Library, Tomáš Horňák, 216324

PROGNOSTIC ROLE OF REBOUND BASOPHILIA DURING CYTOREDUCTION IN PATIENTS WITH CHRONIC MYELOID LEUKAEMIA

EHA Library, Lucia Vrablova, 216325